ABSTRACT NUMBER: ESOC2026YS116 HYPERGLYCAEMIA AUDIT

Abstract Background and aims Hyperglycaemia, commonly seen in diabetes, can worsen outcomes in ischaemic stroke. This audit was done to determine how many patients admitted with ischaemic stroke had a HbA1c level resulted within 3 months preceding their admission date and how many results were consistent with new diabetes diagnosis. Methods We reviewed the clinical notes, presence of and dates for laboratory reported HbA1c results of patients admitted with ischaemic stroke under the stroke department at Kings College Hospital, Denmark Hill in September 2025. Search terms including ‘diabetes’, the acronyms 'DM' and 'DSN' and the 'consultation' entry type were searched for in each patient’s EPIC online record to look for past medical history (PMH) of diabetes and to determine whether patients had undergone review by or discussion with the diabetes specialist team (DSNs), and if so, what their management plans were. Results 90 patients were admitted with ischaemic stroke; 77% had HbA1c results during admission or within 3 months before admission date, 11% of results were reported after discharge. 4% of patients had a HbA1c consistent with diabetes despite negative PMH and 1% had a HbA1c result consistent with diabetes released after discharge, thus limiting inpatient glucose monitoring. Additionally, although 34% of patients had diabetes, 21% were reviewed by the DSNs and varying glucose targets were noted. This audit highlighted earlier HbA1c ordering as a quality improvement opportunity, to optimise glycaemic monitoring and control during inpatient ischaemic stroke management. Conflict of interest Adetoro Akintunde: nothing to disclose, Rabiatul Idham: nothing to disclose.